Drug-related problems among type 2 diabetes mellitus patients with hypertension: a prospective observational study
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20250480Keywords:
Drug-related problems, Drug utilization, Hypertension, Pharmaceutical care, Polypharmacy, Type 2 diabetes mellitusAbstract
Background: Type 2 diabetes mellitus (T2DM) and hypertension (HTN) are common comorbid conditions that pose significant management challenges due to drug-related problems (DRPs), which can adversely affect clinical outcomes. This study aimed to evaluate the prevalence and types of DRPs in T2DM and HTN patients, analyse drug utilization patterns and identify factors influencing DRPs.
Methods: A prospective observational study was conducted over six months at a multi-specialty hospital in Bengaluru. Data from 110 adult patients with T2DM and HTN were collected, including demographics, clinical history and medication records. DRPs were identified using the Pharmaceutical Care Network Europe (PCNE) and Hepler-Strand classifications.
Results: The mean age of the participants was 63.45±13.66 years, with a nearly equal gender distribution. Monotherapy (37.27%) and dual therapy (33.63%) were the most common T2DM treatments, while calcium channel blockers (37.27%) and beta blockers (36.36%) were the predominant antihypertensives. DRPs were observed in 36.36% of patients, with untreated indications (14.54%) and drug-drug interactions (13.63%) being most common. Factors such as smoking and alcohol consumption were associated with higher DRP prevalence.
Conclusions: DRPs significantly impact the management of T2DM and HTN, highlighting the need for regular medication reviews and targeted interventions to optimize therapeutic outcomes in these patients.
Metrics
References
DiPiro JT. Concepts in clinical pharmacokinetics. ASHP. 2010.
Ayele Y, Melaku K, Dechasa M. Assessment of Drug Related Problems among Type 2 Diabetes Mellitus patients with Hypertension in Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia. BMC Research Notes. 2018;11:728. DOI: https://doi.org/10.1186/s13104-018-3838-z
Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda BI. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Prac. 2018;138:271-81. DOI: https://doi.org/10.1016/j.diabres.2018.02.023
Guido LSS, Syed S, Kurukulasuriya LR. Type 2 diabetes mellitus and hypertension: an update. Endocrinol Metab Clin North Am. 2014;43:103–22. DOI: https://doi.org/10.1016/j.ecl.2013.09.005
World Health Organization. DengueNet—WHO’s Internet-based System for the Global Surveillance of Dengue Fever and Dengue Haemorrhagic Fever (Dengue/DHF) Dengue/DHF—global public health burden. Weekly Epidemiological Record= Relevé épidémiologique hebdomadaire. 2002;77(36):300-4.
Adnyana IK. Drug‑related problems in Type 2 diabetic patients with hypertension in Cimahi, West Java, Indonesia: A prospective study. IJGP. 2017;11(2):34-8.
Melcher K, Schlienger R, Lampert M. Drug related problems in Hospitals- A review of the recent literatures; Drug Saf. 2007;30(5):379-407. DOI: https://doi.org/10.2165/00002018-200730050-00003
Pharmaceutical Care Network Europe Association. PCNE Classification for drug-related problems. 2020;1:22-8.
Zaman Huri H, Fun Wee H. Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study. BMC endocrine disorders. 2013;13:1-2.
Abdulmalik H, Tadiwos Y and Legese N. Assessment of drug-related problems among type 2 diabetic patients on follow up at Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia. Abdulmalik BMC Res. 2019;12:771. DOI: https://doi.org/10.1186/s13104-019-4760-8
Zaman Huri H, Fun Wee H. Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study. BMC endocrine disorders. 2013;13:1-2. DOI: https://doi.org/10.1186/1472-6823-13-2
Kefale B, Tegegne GT, Kefale Y, Molla M, Ewunetei A, Degu A. Magnitude and determinants of drug therapy problems among type 2 diabetes mellitus patients with hypertension in Ethiopia. SAGE open medicine. 2020;8:2050312120954695. DOI: https://doi.org/10.1177/2050312120954695
Feyissa D and Bezie Kebede M. Drug-Related Problems and Their Predictors Among Patients with Diabetes Attending the Ambulatory Clinic of Gebre Tsadik Shawo General Hospital, Southwest Ethiopia. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020;4:13. DOI: https://doi.org/10.2147/DMSO.S267790
Inam dar S.Z, Kulkarni R.V. Drug related problems in elderly patients with type 2 diabetes mellitus. J of Diabetology, February 2016;1:1. DOI: https://doi.org/10.4103/2078-7685.198422
Zazuli Z, Rohaya A, Adnyana IK. Drug-related problems in type 2 diabetic patients with hypertension: a prospective study. J Basic Clin Pharm. 2017;8(4):251-4.
Nzayisenga J, Ngomi NN, Nyiligira J. Drug-related problems among type II diabetes mellitus patients with hypertension: a cross-sectional study. Prim Care Diabetes. 2020;10:120.
Mendoza GA, Sánchez-Duque JA. Prescription patterns and costs of antidiabetic medications in a large group of patients. Prim Care Diabetes. 2018;12(2):184-91. DOI: https://doi.org/10.1016/j.pcd.2017.11.002
Nzayisenga J, Ngomi NN, Nyiligira J. Drug-related problems among type II diabetes mellitus patients with hypertension: a cross-sectional study. Prim Care Diabetes. 2020;3(1):22-8. DOI: https://doi.org/10.53388/life2020-0125-101
Downloads
Published
How to Cite
Issue
Section
